{"id":"https://openalex.org/W4293099869","doi":"https://doi.org/10.22533/at.ed.5092218032","title":"CUSTOS DE TRATAMENTO E DA MONITORIZA\u00c7\u00c3O PLASM\u00c1TICA DA VANCOMICINA COMPARADOS AO CUSTO DE TRATAMENTO COMA LINEZOLIDA CONTRA BACT\u00c9RIAS GRAM POSITIVAS","display_name":"CUSTOS DE TRATAMENTO E DA MONITORIZA\u00c7\u00c3O PLASM\u00c1TICA DA VANCOMICINA COMPARADOS AO CUSTO DE TRATAMENTO COMA LINEZOLIDA CONTRA BACT\u00c9RIAS GRAM POSITIVAS","publication_year":2022,"publication_date":"2022-03-18","ids":{"openalex":"https://openalex.org/W4293099869","doi":"https://doi.org/10.22533/at.ed.5092218032"},"language":"pt","primary_location":{"id":"doi:10.22533/at.ed.5092218032","doi":"https://doi.org/10.22533/at.ed.5092218032","is_oa":false,"landing_page_url":"https://doi.org/10.22533/at.ed.5092218032","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ci\u00eancias farmac\u00eauticas: Preven\u00e7\u00e3o, promo\u00e7\u00e3o, prote\u00e7\u00e3o e recupera\u00e7\u00e3o da sa\u00fade","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049891165","display_name":"Milena Oliveira Brand\u00e3o Souza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Milena Oliveira Brand\u00e3o Souza","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034083281","display_name":"Camila Sgarioni Bert\u00e3o","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camila Sgarioni Bert\u00e3o","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061878891","display_name":"Ma\u00edra Rombaldi Alves","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ma\u00edra Rombaldi Alves","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034173275","display_name":"M\u00edrian Nic\u00e9a Zarpellon","orcid":"https://orcid.org/0000-0002-6214-5649","observed_orcids":["https://orcid.org/0000-0002-6214-5649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mirian Nic\u00e9a Zarpellon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074741354","display_name":"Andr\u00e9a Diniz","orcid":"https://orcid.org/0000-0002-9638-9246","observed_orcids":["https://orcid.org/0000-0002-9638-9246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Diniz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081883587","display_name":"Elza Miyuki Kimura","orcid":"https://orcid.org/0000-0002-6466-5074","observed_orcids":["https://orcid.org/0000-0002-6466-5074"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elza Kimura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"*","last_page":"17"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.27559998631477356,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.27559998631477356,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.24819999933242798,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.1688999980688095,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.9549999833106995},{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":0.9860000014305115},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.5979999899864197},{"id":"https://openalex.org/keywords/plasma-drug-monitoring","display_name":"plasma concentration monitoring","score":0.671999990940094},{"id":"https://openalex.org/keywords/gram-positive-bacteria","display_name":"Gram-positive bacteria","score":0.7200000286102295},{"id":"https://openalex.org/keywords/antibiotic-treatment-comparison","display_name":"antibiotic comparison","score":0.40400001406669617},{"id":"https://openalex.org/keywords/cost-analysis","display_name":"cost analysis","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.512069046497345}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22533/at.ed.5092218032","doi":"https://doi.org/10.22533/at.ed.5092218032","is_oa":false,"landing_page_url":"https://doi.org/10.22533/at.ed.5092218032","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ci\u00eancias farmac\u00eauticas: Preven\u00e7\u00e3o, promo\u00e7\u00e3o, prote\u00e7\u00e3o e recupera\u00e7\u00e3o da sa\u00fade","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2750577139","https://openalex.org/W7055630784","https://openalex.org/W2588978365","https://openalex.org/W7042732776","https://openalex.org/W4413282441","https://openalex.org/W2081258278","https://openalex.org/W7015824996","https://openalex.org/W177707336","https://openalex.org/W2583826488","https://openalex.org/W4407032469"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-08-26T00:00:00"}